{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:52:27Z","timestamp":1774979547393,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T00:00:00Z","timestamp":1452211200000},"content-version":"vor","delay-in-days":313,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Servier, Paris"},{"name":"Stichting Wellerdieck-de Goede Fonds, the Netherlands","award":["12.095"],"award-info":[{"award-number":["12.095"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ijcard.2014.12.046","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T05:33:07Z","timestamp":1419312787000},"page":"194-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease \u2014 Results from EUROPA"],"prefix":"10.1016","volume":"182","author":[{"given":"Joep","family":"van der Leeuw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit M.","family":"Oemrawsingh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper J.","family":"Brugts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap W.","family":"Deckers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem J.","family":"Remme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten L.","family":"Simoons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank L.J.","family":"Visseren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2014.12.046_bb0005","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1161\/01.CIR.90.4.2056","article-title":"Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection","volume":"90","author":"Lonn","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0010","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0140-6736(92)92889-N","article-title":"Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions","volume":"340","author":"Yusuf","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0015","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0020","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ehj.2004.06.003","article-title":"Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The task force on ACE-inhibitors of the European Society of Cardiology","volume":"25","author":"L\u00f3pez-Send\u00f3n","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0025","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0030","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/eurheartj\/ehp103","article-title":"The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials","volume":"30","author":"Brugts","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0035","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/eurheartj\/ehi809","article-title":"Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk","volume":"27","author":"Deckers","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0040","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/eurheartj\/ehq169","article-title":"Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease","volume":"31","author":"Brugts","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0045","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1161\/CIRCULATIONAHA.112.000712","article-title":"High-dose statin therapy in patients with stable coronary artery disease: treating the right patients based on individualized prediction of treatment effect","volume":"127","author":"Dorresteijn","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0050","doi-asserted-by":"crossref","first-page":"d5888","DOI":"10.1136\/bmj.d5888","article-title":"Estimating treatment effects for individual patients based on the results of randomised clinical trials","volume":"343","author":"Dorresteijn","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/eurheartj\/ehu004","article-title":"Personalized cardiovascular disease prevention by applying individualized prediction of treatment effects","volume":"35","author":"van der Leeuw","year":"2014","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcard.2014.12.046_bb0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/HYPERTENSIONAHA.114.04421","article-title":"Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from action in diabetes and vascular disease: Preterax and Diamicron MR controlled evaluation","volume":"65","author":"van der Leeuw","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.diabres.2012.05.002","article-title":"Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes","volume":"98","author":"van Dieren","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0070","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1161\/CIRCULATIONAHA.113.002290","article-title":"Using benefit-based tailored treatment to improve the use of antihypertensive medications","author":"Sussman","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0075","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(05)70240-3","article-title":"Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk","volume":"365","author":"Jackson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10557-008-6156-1","article-title":"The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease","volume":"23","author":"Brugts","year":"2009","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1011131130922","article-title":"The EUROPA trial: design, baseline demography and status of the substudies","volume":"15","author":"Gomma","year":"2001","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000159124","article-title":"The renin\u2013angiotensin-aldosterone system: approaches to guide angiotensin-converting enzyme inhibition in patients with coronary artery disease","volume":"112","author":"Brugts","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0100","series-title":"Clinical Prediction Models: A Practical Approach To Development, Validation, and Updating","author":"Steyerberg","year":"2009"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat. Med."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","article-title":"The lasso method for variable selection in the Cox model","volume":"16","author":"Tibshirani","year":"1997","journal-title":"Stat. Med."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/bimj.200900028","article-title":"L1 penalized estimation in the Cox proportional hazards model","volume":"52","author":"Goeman","year":"2010","journal-title":"Biom. J."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1745-6215-11-85","article-title":"Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal","volume":"11","author":"Kent","year":"2010","journal-title":"Trials"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0125","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/heartjnl-2013-303640","article-title":"Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score","volume":"99","author":"Dorresteijn","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jclinepi.2006.01.014","article-title":"Review: a gentle introduction to imputation of missing values","volume":"59","author":"Donders","year":"2006","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00127305","article-title":"A method for checking regression models in survival analysis based on the risk score","volume":"2","author":"Gr\u00f8nnesby","year":"1996","journal-title":"Lifetime Data Anal."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1009612305785","article-title":"A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model","volume":"4","author":"May","year":"1998","journal-title":"Lifetime Data Anal."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-6215-8-14","article-title":"Method for evaluating prediction models that apply the results of randomized trials to individual patients","volume":"8","author":"Vickers","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0150","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2014.12.046_bb0155","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"The SOLVD Investigators","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1042\/CS20130204","article-title":"Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease","volume":"126","author":"Wu","year":"2014","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ijcard.2014.12.046_bb0175","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eururo.2010.10.041","article-title":"Doc, what are my chances? A conversation about prognostic uncertainty","volume":"59","author":"Kattan","year":"2011","journal-title":"Eur. Urol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314024681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527314024681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T01:59:06Z","timestamp":1717639146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527314024681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":35,"alternative-id":["S0167527314024681"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.12.046","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease \u2014 Results from EUROPA","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2014.12.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}